Patent
Trademark
Copyright
Others
Successful Cases
More
Our Success in Patent Invalidation: Challenging “...
Our firm, in collaboration with Beijing Wei Chixue Law Firm, has recently closed...
Our Firm Represented a Trademark Administrative R...
Trademark administrative reconsideration refers to the administrative reconsidera...
Patent

・

 Interpretation of Revision to the Guidelines for Patent Examination (2025)
  The China National Intellectual Property Administration (CNIPA) issued its Decisi...

・

 Announcement of China National Intellectual Property Administration on Adjustments of Fee Schedule and Reduction Policies for Particular Types of Patents (No. 594)
  CNIPA Announcement No. 594 Pursuant to Notice of National Development and Reform...

・

 Notice on Several Issues Relating to Payments for Extended Patent Term
  Pursuant to the rules set forth in Announcement of China National Intellectual Pr...

・

 The Need-to-Know Amendments in the New Rules for the Implementation of China’s Patent Law
  On December 21, 2023, the new Rules for the Implementation of Patent Law (hereina...

・

 Announcement of China National Intellectual Property Administration on the Interim Measures for Handling Relevant Issues after China’s Accession to the Hague Agreement CNIPA Announcement No. 511
  In order to guarantee smooth practice of the Hague Agreement Concerning the Inter...

・

 Announcement of China National Intellectual Property Administration on the Interim Measures for Examination related to the Implementation of the Revised Patent Law CNIPA Announcement No. 510
  In order to guarantee smooth practice of the amended Patent Law and to fulfill th...

・

 Provisions of the Supreme People’s Court on Several Issues Concerning the Application of Law in the Trial of Civil Cases Concerning Patent Disputes Related to Drugs Applied for Registration
  On July 5, 2021, the Supreme Peoples Court released Provisions of the Supreme Peo...

・

 Announcement of National Medical Products Administration on Matters relating to the Measures for the Implementation of Early Resolution Mechanisms for Drug Patent Disputes (Trial) ([2021] No.46)
  Announcement of National Medical Products Administration (NMPA) on Matters relati...

・

 Announcement of National Medical Products Administration and China National Intellectual Property Administration on Promulgation of the Measures for the Implementation of Early Resolution Mechanisms for Drug Patent Disputes (Trial)
  Announcement of National Medical Products Administration and China National Intel...

・

 Announcement of China National Intellectual Property Administration on the Administrative Adjudication Measures for Major Patent Infringement Disputes (No.426)
  Announcement of China National Intellectual Property Administration No.426 CNIPA...